NE-CHMIMO
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | 1373876-11-9 |
| Chemical and physical data | |
| Formula | C26H25NO |
| Molar mass | 367.49 g·mol−1 |
| 3D model (Jmol) | Interactive image |
| |
| |
NE-CHMIMO (CHM-018) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2] NE-CHMIMO is the 1-cyclohexylmethyl (instead of 1-pentyl) analogue of the first-generation synthetic cannabinoid JWH-018. The corresponding cyclohexylmethyl derivative of JWH-081 had also been reported several months earlier.[3]
See also
References
- ↑ Verena Angerer; Philippe Bisel; Bjoern Moosmann; Folker Westphal; Volker Auwärter (June 2016). "Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative "NE-CHMIMO" using flash chromatography, GC-MS, IR and NMR spectroscopy". Forensic Science International. doi:10.1016/j.forsciint.2016.05.031. PMID 27297324.
- ↑ "NE-CHMIMO". New Synthetic Drugs Database.
- ↑ Karen Blakey; Sue Boyd; Sarah Atkinson; Jenna Wolf; Pim M. Slottje; Katrina Goodchild; Jenny McGowan (March 2016). "Identification of the novel synthetic cannabimimetic 8-quinolinyl 4-methyl-3-(1-piperidinylsulfonyl)benzoate (QMPSB) and other designer drugs in herbal incense". Forensic Science International. 260: 40–53. doi:10.1016/j.forsciint.2015.12.001. PMID 26795397.
This article is issued from Wikipedia - version of the 6/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.